cipla pharmaceuticals usa stock price

Full Answer

What is the last price of Cipla stock?

Cipla Ltd. stock last traded price is 910.20 Cipla Ltd. share price moved down by -1.18 % from its previous close of Rs 921.40. Cipla Ltd. stock last traded price is 910.50

What is the history of Cipla company?

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 38561.75 Crore) operating in Pharmaceuticals sector.

What is Cipla’s new ventures?

The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

What are the key products/revenue segments of Cipla?

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 78,968.88 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue, Royalty Income and Scrap for the year ending 31-Mar-2020.

See more

Is Cipla a good buy now?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Cipla Ltd is a good quality company.

Is Cipla available in USA?

Through a comprehensive partnership model approach, Cipla has been dedicated to providing access to medicines at an affordable price for over 30 years in the US. The company has executed over 20 US partnerships and currently has over 1500 commercialized products in the US.

Can I buy Cipla shares?

You can easily buy Cipla shares in Groww by creating a demat account and getting the KYC documents verified online.

Why Cipla shares are going down?

Cipla share trades higher than 50 day moving averages but lower than 5 day, 20 day, 100 day and 200 day moving averages. Shares of Cipla fell nearly 5% today after promoters of the pharma firm sold over 2% stake for Rs 1,844 crore in a block deal.

Is Cipla a good company?

Cipla Pharmaceutical is rated 4.1 out of 5, based on 4.6k reviews by employees on AmbitionBox. Cipla Pharmaceutical is known for Skill development which is rated at the top and given a rating of 4.1. However, Job Security is rated the lowest at 3.6 and can be improved.

What happened to Cipla?

CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2022.In terms of the Companys Code of Conduct for Prevention of Insider Trading ...

Is Cipla a debt free company?

Company is almost debt free.

What is the future of Cipla shares?

Cipla Ltd. quote is equal to 967.700 INR at 2022-07-29. Based on our forecasts, a long-term increase is expected, the "Cipla Ltd" stock price prognosis for 2027-07-23 is 1938.650 INR. With a 5-year investment, the revenue is expected to be around +100.34%.

Which share is best to buy?

Stocks to Buy Today: Best Shares to Buy in IndiaNameLTPHighAxis Bank728.00735B P C L328.40330Bajaj Auto3,901.103,952Bajaj Finance7,202.407,26011 more rows

Is Cipla good for long term investment?

While Covid-related sales may come down going ahead, analysts expect the company's domestic sales to outperform the market, led by the chronics portfolio, which accounts for 55 per cent of sales.

Is Cipla an Indian company?

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions.

Why are Lupin shares falling?

Overall, Lupin reported a loss for the quarter. “Lupin has taken an expense on account of the impairment of Gavis IPs to the tune of ₹130 crore. Adjusting for the aforementioned exceptional items, Lupin reported a loss of ₹2.4 crore, due to higher tax outgo," said analysts from Motilal Oswal.

Which year Cipla was approved by the FDA?

1985In the year 1985 US FDA approved the company's bulk drug manufacturing facilities. In the year 1988 they won National Award for Successful Commercialisation of Publicly Funded R&D.

Where are Cipla drugs made?

This year (2017-18), we commenced commercial production at our state-of-the-art manufacturing unit for formulations at Sikkim II. We also ensured the formulation manufacturing of existing facilities at Indore and Goa to service increasing demand across markets.

What is Cipla tablet used for?

What it is used for. Temporary symptomatic relief of rhinorrhoea, nasal congestion, headache, myalgia and fever in patient aged 12 years and over. The night tablets also provide temporary symptomatic relief from sneezing and itchy watery eyes.

What is Cipla medicine used for?

Cipla Inhaler is a medicine used to treat various heart conditions such as hypertension (high blood pressure), angina (heart-related chest pain), arrhythmia (irregular heart rhythm), migraine, and tremor.

What is Cipla share price and what are the returns for Cipla share?

As on 08 Jun, 2022, 03:57 PM IST Cipla share price was down by 1.01% basis the previous closing price of Rs 976.05. Cipla share price was Rs 962.95...

Is Cipla a good buy?

As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 38 analysts for Cipla stock is to Buy. Recommendation breakup is as fo...

Who's the owner of Cipla?

Promoter,DII and FII owns 36.11, 17.86 and 28.01 shares of Cipla as on 31 Mar 2022Promoter holding have gone down from 36.11 (31 Dec 2021) to 33.63...

What is the market cap of Cipla?

Market Capitalization of Cipla stock is Rs 77,752.67 Cr.

What has been highest price of Cipla share in last 52 weeks?

52 Week high of Cipla share is Rs 1,083.00 while 52 week low is Rs 850.00

Which are the key peers to Cipla?

Within Pharmaceuticals sector Cipla, Dr. Reddy's Laboratories Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Gland Pharma Ltd., Bioc...

How can I quickly analyze Cipla stock?

Key Metrics for Cipla are: PE Ratio of Cipla is 30.87 Earning per share of Cipla is 31.19 Price/Sales ratio of Cipla is 3.78 Price to Book ratio of...

What is the 500087?

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA).

Who is Merck partnering with?

Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd , to expand production and access to its experimental COVID-19 drug. The partnership will give the companies license to supply Merck's molnupiravir to India and more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies, Merck said. Merck said the move is to help address the raging new wave of COVID-19 in India, which has reported more than 300,000 new COVID-19 cases per day over the past six days.

How many doses of Moderna 2022?

Cipla has already evinced interest in procuring 50 million doses from Moderna for 2022 and has requested confirmation from the central government. Today, Moderna said that its vaccine is effective for 12 to 17 year-olds; it will seek FDA approval.

Is Cipla available in India?

Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.

Does Eli Lilly have a deal with India?

Eli Lilly signs deals to boost supply of COVID-19 treatment in India. BENGALURU (Reuters) -Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.

Is Cipla used in India?

regulators and the scientific opinion of a European regulatory panel, Roche's India distribution partner for the drug, Cipla , said on Wednesday. The drug already has similar authorization in the United States and is used in Europe non-hospitalised patients.

Does Cipla sell to Eli Lilly?

India's Cipla has signed a deal with Eli Lilly to sell and distribute two of the U. S. drugmaker's best-selling diabetes treatments in the country, the companies said in a joint statement on Monday. Lilly will transfer its rights in India to sell, promote and distribute its Trulicity and Humalog products, while continuing to maintain its existing operating model for the remaining portfolio of its products, the companies said. The deal will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world.

What is Cipla Ltd?

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 78,968.88 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue, Royalty Income and Scrap for the year ending 31-Mar-2020.

What is face value of stock?

Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value. (₹) -.

How to calculate MCap?

MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.

What is a stock score?

Stock Score is the Average Score from Stock Reports Plus by Refinitiv which combines quantitative analysis of widely used investment decision making tools. This score is on a 10 point scale (1 is lowest and 10 being the highest, NR indicates No-rating is available)

How many stocks can you access with ET Prime?

You can access 4000+ Stock Reports with ET Prime. Know More

What is the 500087?

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA).

Who is Merck partnering with?

Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd , to expand production and access to its experimental COVID-19 drug. The partnership will give the companies license to supply Merck's molnupiravir to India and more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies, Merck said. Merck said the move is to help address the raging new wave of COVID-19 in India, which has reported more than 300,000 new COVID-19 cases per day over the past six days.

How many doses of Moderna 2022?

Cipla has already evinced interest in procuring 50 million doses from Moderna for 2022 and has requested confirmation from the central government. Today, Moderna said that its vaccine is effective for 12 to 17 year-olds; it will seek FDA approval.

Is Cipla used in India?

regulators and the scientific opinion of a European regulatory panel, Roche's India distribution partner for the drug, Cipla , said on Wednesday. The drug already has similar authorization in the United States and is used in Europe non-hospitalised patients.

Is Cipla available in India?

Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.

What is Cipla Foundation?

With Cipla Foundation, we envision and execute Cipla’s Corporate Social Responsibility. In the last year, we have reached out to over 2,20,000 individuals in the community across in Health, Education, Skilling and Disaster Response.

Who is the chairman of Cipla?

As a book commemorating Cipla’s 85-year journey nears publication, Cipla Chairman Yusuf K Hamied, the grand old man of Indian pharma, talks about a lifelong mission to make drugs affordable and the need for ‘incremental innovation’.

What is Cipla Palliative Care Project?

As we could see in our virtual visit, The Cipla Palliative Care Project is an initiative that defines Cipla’s focus on human values and devotion towards humankind’s welfare. I totally identify with Cipla´s business model, and I am proud to be part of a company that takes responsibility of the society’s well-being and leads by an example.

What is Cipla's reimagination?

Cipla is embarking on a strategic 'Reimagination' journey, which aims to create multiple dimensions of automated equipment, data-driven decision making and performance enhancements.

Is Cipla a good company?

My journey with Cipla began in October 2019 and after joining I realized that the work environment and culture here is excellent. A huge pharmaceutical company, with a diversified work force and good policies makes Cipla a perfect employer of choice for me. During this pandemic, I really appreciate Cipla’s team for taking care of all employees and their families by providing medicines, arranging hospital beds and hotel for quarantine. In case of any untimely death, the kind of financial, medical and educational support is provided to employee’s family is really unbelievable.

Does Cipla have boundaries?

There is a true sense of respect, belonging and involvement at each level. Cipla does not believe in boundaries and there is always encouragement to learn and evolve.

Can you sell Tocilizumab in India?

Ministry of Health & Family Welfare / Department of Pharmaceuticals ordered all-India supply of Tocilizumab & Amphotericin to be only through authorised Government & private hospitals. No individual, distributor or retailer can sell these medicines to the public.

News

What should investors do with Cipla post Q3 earnings; buy, sell or hold? Jan 27 2022 09:01 AM

Corporate Action

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and A....

About the Company

Cipla Ltd focuses on the development of new formulations and has a wide range of pharmaceutical products.